Unknown

Dataset Information

0

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.

ABSTRACT: Glycosylation is a ubiquitous post-translational modification, present in over 50?% of the proteins in the human genome,1 with important roles in cell-cell communication and migration. Interest in glycome profiling has increased with the realization that glycans can be used as biomarkers of many diseases,2 including cancer.3 We report here the first tomographic imaging of glycosylated tissues in live mice by using metabolic labeling and a gadolinium-based bioorthogonal MRI probe. Significant N-azidoacetylgalactosamine dependent T1?contrast was observed in?vivo two hours after probe administration. Tumor, kidney, and liver showed significant contrast, and several other tissues, including the pancreas, spleen, heart, and intestines, showed a very high contrast (>10-fold). This approach has the potential to enable the rapid and non-invasive magnetic resonance imaging of glycosylated tissues in?vivo in preclinical models of disease.

SUBMITTER: Neves AA 

PROVIDER: S-EPMC4848764 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.

Neves André A AA   Wainman Yéléna A YA   Wright Alan A   Kettunen Mikko I MI   Rodrigues Tiago B TB   McGuire Sarah S   Hu De-En DE   Bulat Flaviu F   Geninatti Crich Simonetta S   Stöckmann Henning H   Leeper Finian J FJ   Brindle Kevin M KM  

Angewandte Chemie (Weinheim an der Bergstrasse, Germany) 20151203 4

Glycosylation is a ubiquitous post-translational modification, present in over 50 % of the proteins in the human genome,1 with important roles in cell-cell communication and migration. Interest in glycome profiling has increased with the realization that glycans can be used as biomarkers of many diseases,2 including cancer.3 We report here the first tomographic imaging of glycosylated tissues in live mice by using metabolic labeling and a gadolinium-based bioorthogonal MRI probe. Significant <i>  ...[more]

Similar Datasets

Unknown Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.
| S-EPMC4737346 | biostudies-literature
Unknown Bacteria tracking by in vivo magnetic resonance imaging.
| S-EPMC3686665 | biostudies-literature
Unknown Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging.
| S-EPMC5226623 | biostudies-literature
Methylation profiling Genomic Evaluation of Multiparametric Magnetic Resonance Imaging -visible and -nonvisible Lesions in Clinically Localized Prostate Cancer
2018-12-01 | GSE101908 | GEO
Unknown Feasibility of Arterial Spin Labeling Magnetic Resonance Imaging for Musculoskeletal Tumors with Optimized Post-Labeling Delay.
| S-EPMC9600497 | biostudies-literature
Unknown Facile synthetic route for surface-functionalized magnetic nanoparticles: cell labeling and magnetic resonance imaging studies.
| S-EPMC4060805 | biostudies-literature
Unknown In vivo magnetic resonance imaging of treatment-induced apoptosis.
| S-EPMC6606573 | biostudies-literature
Unknown Magnetic resonance imaging during warm ex vivo kidney perfusion.
| S-EPMC10086841 | biostudies-literature
Unknown Metabolic labeling and direct imaging of choline phospholipids in vivo.
| S-EPMC2741251 | biostudies-literature
Transcriptomics The STEMRI trial: magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma-stem-like cells
2023-11-03 | GSE239379 | GEO